Omega-3 Phospholipids from Krill Oil Enhance Intestinal Fatty Acid Oxidation More Effectively Than Omega-3 Triacylglycerols in High-Fat Diet-Fed Obese Mice
Overview
Authors
Affiliations
Antisteatotic effects of omega-3 fatty acids (Omega-3) in obese rodents seem to vary depending on the lipid form of their administration. Whether these effects could reflect changes in intestinal metabolism is unknown. Here, we compare Omega-3-containing phospholipids (krill oil; ω3PL-H) and triacylglycerols (ω3TG) in terms of their effects on morphology, gene expression and fatty acid (FA) oxidation in the small intestine. Male C57BL/6N mice were fed for 8 weeks with a high-fat diet (HFD) alone or supplemented with 30 mg/g diet of ω3TG or ω3PL-H. Omega-3 index, reflecting the bioavailability of Omega-3, reached 12.5% and 7.5% in the ω3PL-H and ω3TG groups, respectively. Compared to HFD mice, ω3PL-H but not ω3TG animals had lower body weight gain (-40%), mesenteric adipose tissue (-43%), and hepatic lipid content (-64%). The highest number and expression level of regulated intestinal genes was observed in ω3PL-H mice. The expression of FA ω-oxidation genes was enhanced in both Omega-3-supplemented groups, but gene expression within the FA β-oxidation pathway and functional palmitate oxidation in the proximal ileum was significantly increased only in ω3PL-H mice. In conclusion, enhanced intestinal FA oxidation could contribute to the strong antisteatotic effects of Omega-3 when administered as phospholipids to dietary obese mice.
Pham T, Hoang T, Cao P, Le T, Ho V, Vu T Food Chem X. 2025; 24:101880.
PMID: 39974718 PMC: 11838114. DOI: 10.1016/j.fochx.2024.101880.
Katare P, Dalmao-Fernandez A, Mengeste A, Navabakbar F, Hamarsland H, Ellefsen S Front Nutr. 2024; 11:1452768.
PMID: 39555189 PMC: 11565515. DOI: 10.3389/fnut.2024.1452768.
EPA and DHA Enhance CACT Promoter Activity by GABP/NRF2.
Stanca E, Spedicato F, Giudetti A, Giannotti L, Di Chiara Stanca B, Damiano F Int J Mol Sci. 2024; 25(16).
PMID: 39201781 PMC: 11354350. DOI: 10.3390/ijms25169095.
Sabinari I, Horakova O, Cajka T, Kleinova V, Wieckowski M, Rossmeisl M Physiol Res. 2024; 73(Suppl 1):S295-S320.
PMID: 39016154 PMC: 11412347. DOI: 10.33549/physiolres.935396.
Omega-3 PUFAs prevent bone impairment and bone marrow adiposity in mouse model of obesity.
Benova A, Ferencakova M, Bardova K, Funda J, Prochazka J, Spoutil F Commun Biol. 2023; 6(1):1043.
PMID: 37833362 PMC: 10575870. DOI: 10.1038/s42003-023-05407-8.